[1]
Dwipoyono, B. et al. 2017. COST ANALYSIS OF TAXANE-BASED AND CISPLATIN-BASED CHEMOTHERAPY REGIMENS FOR EPITHELIAL OVARIAN CANCER IN DHARMAIS NATIONAL CANCER HOSPITAL. International Journal of Applied Pharmaceutics. 9, (Oct. 2017), 172–175. DOI:https://doi.org/10.22159/ijap.2017.v9s1.82_89.